(ASB) Associated Banc-Corp - Overview
Stock: Commercial Loans, Mortgages, Deposits, Cash Management, Investment Services
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.75% |
| Yield on Cost 5y | 5.84% |
| Yield CAGR 5y | 5.18% |
| Payout Consistency | 89.9% |
| Payout Ratio | 33.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 31.0% |
| Relative Tail Risk | -12.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.58 |
| Alpha | 3.87 |
| Character TTM | |
|---|---|
| Beta | 1.138 |
| Beta Downside | 1.268 |
| Drawdowns 3y | |
|---|---|
| Max DD | 39.58% |
| CAGR/Max DD | 0.31 |
Description: ASB Associated Banc-Corp January 10, 2026
Associated Banc-Corp (NYSE:ASB) is a regional bank holding company headquartered in Green Bay, Wisconsin, serving individuals and businesses across Wisconsin, Illinois, Missouri, Minnesota and, via loan production offices, in Indiana, Kansas, Michigan, New York, Ohio and Texas. Its product suite spans commercial and residential lending (including CRE, construction, asset-based and auto finance), deposit and cash-management services, fiduciary and institutional asset-management offerings, and a full line of consumer banking channels such as online banking, cards and money-transfer services.
Key recent metrics highlight the bank’s positioning: Q4 2023 net interest margin (NIM) held at 3.45 %, loan growth accelerated to 7.2 % YoY driven by commercial real-estate demand, and the efficiency ratio improved to 58.3 % reflecting tighter cost control. The company’s CET1 capital ratio sits at 12.4 %, comfortably above the regulatory minimum, while its loan-to-deposit ratio of 81 % indicates a balanced funding profile. Sector-wide, regional banks like ASB are sensitive to the Federal Reserve’s rate-hiking cycle, which can boost NIM but also pressure credit quality in rate-sensitive loan portfolios.
For a deeper quantitative dive, you might explore ValueRay’s analyst tools to benchmark ASB’s performance against peers and assess forward-looking risk factors.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 474.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 0.34 > 1.0 |
| NWC/Revenue: -1303 % < 20% (prev -1455 %; Δ 151.6% < -1%) |
| CFO/TA 0.01 > 3% & CFO 604.7m > Net Income 474.8m |
| Net Debt (-574.7m) to EBITDA (653.0m): -0.88 < 3 |
| Current Ratio: 0.16 > 1.5 & < 3 |
| Outstanding Shares: last quarter (166.7m) vs 12m ago 5.73% < -2% |
| Gross Margin: 58.19% > 18% (prev 0.45%; Δ 5774 % > 0.5%) |
| Asset Turnover: 5.56% > 50% (prev 4.89%; Δ 0.67% > 0%) |
| Interest Coverage Ratio: 0.43 > 6 (EBITDA TTM 653.0m / Interest Expense TTM 971.2m) |
Altman Z'' -4.22
| A: -0.71 (Total Current Assets 6.13b - Total Current Liabilities 38.09b) / Total Assets 45.20b |
| B: 0.07 (Retained Earnings 3.13b / Total Assets 45.20b) |
| C: 0.01 (EBIT TTM 415.0m / Avg Total Assets 44.11b) |
| D: 0.12 (Book Value of Equity 4.98b / Total Liabilities 40.23b) |
| Altman-Z'' Score: -4.22 = D |
Beneish M -3.26
| DSRI: 0.82 (Receivables 161.1m/167.8m, Revenue 2.45b/2.10b) |
| GMI: 0.77 (GM 58.19% / 44.87%) |
| AQI: 1.00 (AQ_t 0.86 / AQ_t-1 0.86) |
| SGI: 1.16 (Revenue 2.45b / 2.10b) |
| TATA: -0.00 (NI 474.8m - CFO 604.7m) / TA 45.20b) |
| Beneish M-Score: -3.26 (Cap -4..+1) = AA |
What is the price of ASB shares?
Over the past week, the price has changed by +7.74%, over one month by +9.30%, over three months by +17.39% and over the past year by +18.94%.
Is ASB a buy, sell or hold?
- StrongBuy: 1
- Buy: 1
- Hold: 8
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ASB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 30.2 | 2.8% |
| Analysts Target Price | 30.2 | 2.8% |
| ValueRay Target Price | 33.1 | 12.7% |
ASB Fundamental Data Overview February 02, 2026
P/E Forward = 9.6339
P/S = 3.1565
P/B = 0.9495
P/EG = 2.27
Revenue TTM = 2.45b USD
EBIT TTM = 415.0m USD
EBITDA TTM = 653.0m USD
Long Term Debt = 1.00b USD (from longTermDebt, two quarters ago)
Short Term Debt = 3.21b USD (from shortTermDebt, two quarters ago)
Debt = 4.21b USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = -574.7m USD (from netDebt column, last quarter)
Enterprise Value = 2.77b USD (4.53b + Debt 4.21b - CCE 5.97b)
Interest Coverage Ratio = 0.43 (Ebit TTM 415.0m / Interest Expense TTM 971.2m)
EV/FCF = 4.92x (Enterprise Value 2.77b / FCF TTM 562.9m)
FCF Yield = 20.34% (FCF TTM 562.9m / Enterprise Value 2.77b)
FCF Margin = 22.96% (FCF TTM 562.9m / Revenue TTM 2.45b)
Net Margin = 19.36% (Net Income TTM 474.8m / Revenue TTM 2.45b)
Gross Margin = 58.19% ((Revenue TTM 2.45b - Cost of Revenue TTM 1.03b) / Revenue TTM)
Gross Margin QoQ = 61.30% (prev 57.98%)
Tobins Q-Ratio = 0.06 (Enterprise Value 2.77b / Total Assets 45.20b)
Interest Expense / Debt = 5.56% (Interest Expense 234.4m / Debt 4.21b)
Taxrate = 15.82% (25.8m / 162.9m)
NOPAT = 349.4m (EBIT 415.0m * (1 - 15.82%))
Current Ratio = 0.16 (Total Current Assets 6.13b / Total Current Liabilities 38.09b)
Debt / Equity = 0.85 (Debt 4.21b / totalStockholderEquity, last quarter 4.98b)
Debt / EBITDA = -0.88 (Net Debt -574.7m / EBITDA 653.0m)
Debt / FCF = -1.02 (Net Debt -574.7m / FCF TTM 562.9m)
Total Stockholder Equity = 4.83b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.08% (Net Income 474.8m / Total Assets 45.20b)
RoE = 9.83% (Net Income TTM 474.8m / Total Stockholder Equity 4.83b)
RoCE = 7.12% (EBIT 415.0m / Capital Employed (Equity 4.83b + L.T.Debt 1.00b))
RoIC = 4.25% (NOPAT 349.4m / Invested Capital 8.22b)
WACC = 7.49% (E(4.53b)/V(8.74b) * Re(10.11%) + D(4.21b)/V(8.74b) * Rd(5.56%) * (1-Tc(0.16)))
Discount Rate = 10.11% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 5.40%
[DCF Debug] Terminal Value 79.94% ; FCFF base≈492.8m ; Y1≈490.7m ; Y5≈515.0m
Fair Price DCF = 64.06 (EV 10.06b - Net Debt -574.7m = Equity 10.63b / Shares 166.0m; r=7.49% [WACC]; 5y FCF grow -1.10% → 2.90% )
EPS Correlation: 48.11 | EPS CAGR: 15.24% | SUE: 4.0 | # QB: 6
Revenue Correlation: 66.26 | Revenue CAGR: 24.44% | SUE: 4.0 | # QB: 14
EPS next Quarter (2026-03-31): EPS=0.68 | Chg30d=+0.014 | Revisions Net=+4 | Analysts=8
EPS current Year (2026-12-31): EPS=2.86 | Chg30d=+0.030 | Revisions Net=+2 | Growth EPS=+1.6% | Growth Revenue=+13.6%
EPS next Year (2027-12-31): EPS=3.18 | Chg30d=+0.056 | Revisions Net=+2 | Growth EPS=+11.3% | Growth Revenue=+8.4%